Alliance Pharma PLC APH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if APH is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- GBX 35.00
- Day Range
- GBX 34.25–35.20
- 52-Week Range
- GBX 33.70–73.04
- Bid/Ask
- GBX 35.00 / GBX 35.10
- Market Cap
- GBX 18.96 Bil
- Volume/Avg
- 427,003 / 932,276
Key Statistics
- Price/Earnings (Normalized)
- 10.90
- Price/Sales
- 1.12
- Dividend Yield (Trailing)
- 3.38%
- Dividend Yield (Forward)
- —
- Total Yield
- 3.38%
Company Profile
Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 285
Comparables
Valuation
|
Metric
|
APH
|
DWF
|
IPEL
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.90 | 8.98 | 58.61 |
Price/Book Value | 0.71 | 7.24 | 2.45 |
Price/Sales | 1.12 | 0.85 | 0.23 |
Price/Cash Flow | 8.61 | 6.01 | 10.95 |
Price/Earnings
APH
DWF
IPEL
Financial Strength
|
Metric
|
APH
|
DWF
|
IPEL
|
|---|---|---|---|
Quick Ratio | 1.33 | 1.78 | 1.09 |
Current Ratio | 1.93 | 1.93 | 1.09 |
Interest Coverage | 0.31 | 3.39 | 3.62 |
Quick Ratio
APH
DWF
IPEL
Profitability
|
Metric
|
APH
|
DWF
|
IPEL
|
|---|---|---|---|
Return on Assets (Normalized) | 3.00% | 9.44% | 2.00% |
Return on Equity (Normalized) | 5.78% | 73.80% | 9.76% |
Return on Invested Capital (Normalized) | 5.22% | 15.38% | 8.14% |
Return on Assets
APH
DWF
IPEL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Hkknxzjwn | Lhnksjb | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Lhvfrmxwy | Svqk | $68.9 Bil | |
HLN
| Haleon PLC ADR | Cvgxbnv | Twst | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Wcxyxprm | Yng | $14.7 Bil | |
VTRS
| Viatris Inc | Qkkcxzy | Phrw | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qwmtjht | Fthk | $11.9 Bil | |
CTLT
| Catalent Inc | Qxrtkbhx | Zyjjwhp | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Lznxchtqg | Fytd | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Mffttzh | Ctbx | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Gjzxkcjpb | Ghbvpv | $3.5 Bil |